VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ORIOld Republic International Corporation
$41.23$10.0B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksORIQuarterly Financials

Old Republic International Corporation (ORI) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Old Republic International Corporation (ORI) quarterly income statement — complete revenue, gross profit & net income history

ORI Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Revenue2.4B2.34B2.42B2.21B2.11B2B2.34B1.87B2.02B1.94B1.76B1.8B
Revenue Growth %13.51%16.94%3.53%17.98%4.88%3.17%33.03%4.09%14.63%-17.24%2.28%-0.66%
Medical Costs & Claims840.2M2.06B852.3M826.5M772.1M788.8M809.4M731.5M694.6M709.5M657.4M612.8M
Medical Cost Ratio %35.02%88.02%35.16%37.43%36.52%39.39%34.57%39.08%34.46%36.55%37.35%34.08%
Gross Profit1.56B280.5M1.57B1.38B1.34B1.21B1.53B1.14B1.32B1.23B1.1B1.19B
Gross Margin %64.98%11.98%64.84%62.57%63.48%60.61%65.43%60.92%65.54%63.45%62.65%65.92%
Gross Profit Growth %16.19%-76.89%2.59%21.19%1.57%-1.45%38.94%-3.81%14.06%-30.9%0.56%0.93%
Operating Expenses1.15B17.4M1.22B1.12B1.03B1.08B1.11B1.03B922.6M994.1M1.04B988.6M
OpEx / Revenue %47.75%0.74%50.29%50.8%48.92%54.06%47.21%54.86%45.77%51.22%59.02%54.98%
Depreciation & Amortization00000000033M00
Combined Ratio %82.77%88.77%85.45%88.23%85.45%93.45%81.78%93.95%80.23%87.77%96.38%89.06%
Operating Income413.4M263.1M352.7M259.9M307.6M131.2M426.6M113.3M398.4M237.4M63.8M196.7M
Operating Margin %17.23%11.23%14.55%11.77%14.55%6.55%18.22%6.05%19.77%12.23%3.62%10.94%
Operating Income Growth %34.4%100.53%-17.32%129.39%-22.79%-44.73%568.65%-42.4%60.06%-63.41%153.21%457.64%
EBITDA431.1M263.1M370.2M277.7M325.5M148M448.2M135.5M415.1M270.4M80.3M217.6M
EBITDA Margin %17.97%11.23%15.27%12.58%15.4%7.39%19.14%7.24%20.59%13.93%4.56%12.1%
Interest Expense17.7M17.4M17.3M17.6M17.8M17.3M21.3M22.2M16.4M16.5M16.4M20.7M
Non-Operating Income-17.7M0-17.5M-17.8M-17.9M-16.8M-21.6M-22.2M-16.7M-16.5M-16.5M-20.9M
Pretax Income413.4M263.1M352.9M260.1M307.7M130.7M426.9M113.3M398.7M237.4M63.9M196.9M
Pretax Margin %17.23%11.23%14.56%11.78%14.56%6.53%18.23%6.05%19.78%12.23%3.63%10.95%
Income Tax83.8M55.8M72.8M51.7M61.6M25.5M88M21.4M81.9M46.7M11.3M41.3M
Effective Tax Rate %20.27%21.21%20.63%19.88%20.02%19.51%20.61%18.89%20.54%19.67%17.68%20.98%
Net Income330M207.2M279.5M204.4M245M105.1M338.9M91.8M316.7M190.6M52.6M155.5M
Net Margin %13.75%8.85%11.53%9.26%11.59%5.25%14.47%4.9%15.71%9.82%2.99%8.65%
Net Income Growth %34.69%97.15%-17.53%122.66%-22.64%-44.86%544.3%-40.96%58.51%-62.78%157.36%487.78%
EPS (Diluted)1.320.831.110.810.980.421.320.351.150.690.190.54
EPS Growth %34.69%97.62%-15.91%131.43%-14.78%-39.13%594.74%-35.19%69.12%-59.17%163.33%515.38%
EPS (Basic)1.350.851.140.841.010.431.350.351.170.700.190.54
Diluted Shares Outstanding249.64M249.64M249.64M249.64M249.64M250.24M256.74M262.29M275.39M277.23M279.92M287.88M